You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 4, 2024

NEOMYCIN AND POLYMYXIN B SULFATES AND DEXAMETHASONE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Neomycin And Polymyxin B Sulfates And Dexamethasone, and when can generic versions of Neomycin And Polymyxin B Sulfates And Dexamethasone launch?

Neomycin And Polymyxin B Sulfates And Dexamethasone is a drug marketed by Bausch And Lomb, Padagis Us, and Alcon Pharms Ltd. and is included in three NDAs.

The generic ingredient in NEOMYCIN AND POLYMYXIN B SULFATES AND DEXAMETHASONE is dexamethasone; neomycin sulfate; polymyxin b sulfate. There are thirty-nine drug master file entries for this compound. Seventeen suppliers are listed for this compound. Additional details are available on the dexamethasone; neomycin sulfate; polymyxin b sulfate profile page.

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for NEOMYCIN AND POLYMYXIN B SULFATES AND DEXAMETHASONE?
  • What are the global sales for NEOMYCIN AND POLYMYXIN B SULFATES AND DEXAMETHASONE?
  • What is Average Wholesale Price for NEOMYCIN AND POLYMYXIN B SULFATES AND DEXAMETHASONE?
Summary for NEOMYCIN AND POLYMYXIN B SULFATES AND DEXAMETHASONE
US Patents:0
Applicants:3
NDAs:3
Finished Product Suppliers / Packagers: 7
What excipients (inactive ingredients) are in NEOMYCIN AND POLYMYXIN B SULFATES AND DEXAMETHASONE?NEOMYCIN AND POLYMYXIN B SULFATES AND DEXAMETHASONE excipients list
DailyMed Link:NEOMYCIN AND POLYMYXIN B SULFATES AND DEXAMETHASONE at DailyMed
Drug patent expirations by year for NEOMYCIN AND POLYMYXIN B SULFATES AND DEXAMETHASONE
Pharmacology for NEOMYCIN AND POLYMYXIN B SULFATES AND DEXAMETHASONE

US Patents and Regulatory Information for NEOMYCIN AND POLYMYXIN B SULFATES AND DEXAMETHASONE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Bausch And Lomb NEOMYCIN AND POLYMYXIN B SULFATES AND DEXAMETHASONE dexamethasone; neomycin sulfate; polymyxin b sulfate OINTMENT;OPHTHALMIC 064063-001 Jul 25, 1994 AT RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Padagis Us NEOMYCIN AND POLYMYXIN B SULFATES AND DEXAMETHASONE dexamethasone; neomycin sulfate; polymyxin b sulfate OINTMENT;OPHTHALMIC 062938-001 Jul 31, 1989 AT RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Alcon Pharms Ltd NEOMYCIN AND POLYMYXIN B SULFATES AND DEXAMETHASONE dexamethasone; neomycin sulfate; polymyxin b sulfate SUSPENSION/DROPS;OPHTHALMIC 062721-001 Nov 17, 1986 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.